Company & Sponsor Intelligence
University Hospital Tuebingen
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting0
Completed5
Countries1
Therapeutic footprint
adhddementia_otherdepressionneuromuscularother_neurologyout_of_scopeparkinsons
Indexed studies
NCT00518024Safety and Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
other_neurology · GermanyPHASE2
other_neurology · GermanyPHASE2
NCT02572180A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)
adhd · GermanyNA
adhd · GermanyNA
NCT04420650Improving Insulin Sensitivity by Non-invasive Brain Stimulation
out_of_scope · GermanyNA
out_of_scope · GermanyNA
NCT04367350Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement
neuromuscular · GermanyUNKNOWN
neuromuscular · GermanyUNKNOWN
NCT03104088Studying Cognition in SPG4
dementia_other · GermanyCOMPLETED
dementia_other · GermanyCOMPLETED
NCT02375308Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression
depression · GermanyNA
depression · GermanyNA
NCT01355835Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease
parkinsons · GermanyPHASE2
parkinsons · GermanyPHASE2
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →